partnering

News

Ginkgo Bioworks scales up again with M&A frenzy

Ginkgo Bioworks has been busy, announcing not just one but three acquisitions and the creation of a network backed by 25 partners that will offer ‘end-to-end’ services to

News

Viatris splashes out $350m on pair of Idorsia therapies

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus

News

AbbVie inks $713m deal for OSE chronic inflammation drug

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Im

News

Novo Nordisk joins molecular glue club with Neomorph deal

Big pharma’s interest in using protein degradation as a therapeutic strategy shows no sign of abating, as Novo Nordisk signs a wide-ranging deal with US biotech Neomorph t

News

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Astellas has signed an R&D and licensing deal with Kelonia Therapeutics that aims to develop CAR-T therapies for cancer that will push the boundaries of what can be ac

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

Ginkgo Bioworks scales up again with M&A frenzy

Viatris splashes out $350m on pair of Idorsia therapies

AbbVie inks $713m deal for OSE chronic inflammation drug

Novo Nordisk joins molecular glue club with Neomorph deal

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Roche, PathAI team up on AI companion diagnostics

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

partnering

Editor's Picks